Activity Overview
This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of heart failure (HF) in patients with chronic kidney disease (CKD), with a forward-looking perspective on how new and novel agents might affect clinical practice. The essentials of HF and CKD disease classification, clinical trial data, and current and emerging treatment strategies will be reviewed.
System requirements for this online activity are available here.
The activity is free to all users.
Target Audience
This educational activity is directed toward cardiologists, nephrologists, primary care physicians, nurse practitioners, physician assistants, nurses, pharmacists, and other health care professionals involved in the management of edema in patients with CKD and HF.
Learning Objectives
Upon successful completion of this activity, you should be better
prepared to:
- Design individualized strategies to manage fluid overload in patients with CKD
Amir Kazory, MD, FASN, FAHA
Professor and Chief
J. Robert Cade Chair in Nephrology
Division of Nephrology, Hypertension, and Renal Transplantation
University of Florida Health
Gainesville, FL
Disclosures: Dr Kazory has no relevant financial relationships with ineligible companies.
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This accredited continuing education activity
was planned in accordance with the ACCME Standards for Integrity and
Independence to ensure balance, objectivity, independence, and scientific
rigor. Faculty were instructed to use generic names when possible and to base
recommendations on the best available evidence. Proprietary product names may
be referenced in clinical discussion for educational purposes only and do not
imply endorsement.
This activity may include discussion of
investigational, unapproved, or off‑label uses of
drugs or devices. Learners are advised to consult prescribing information for
products discussed. Content is provided for educational purposes only and is
not a substitute for the independent clinical judgment of a health care
professional. Learners are encouraged to critically evaluate the information
presented and apply their own clinical judgment.
The views expressed are those of the individual faculty members and do not necessarily reflect the views of the accredited provider or any entity providing commercial support.
This activity may have used AI-assisted tools
to support educational development. All content was reviewed and approved by
qualified faculty or planners. The accredited provider retains full
responsibility for accuracy, balance, and independence.

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
